ゲノム編集の決定版ガイド。
メニュー
ホーム 学ぶ ニュース Atlasに聞く
探索する 技術 疾患 治療法 臨床試験 企業 科学者 遺伝子 研究 研究機関
医療を超えて 農業 倫理 投資 世界地図
学ぶ・ツール まずはここから 用語集 A~Z 技術を比較する タイムライン リスト・ランキング AIエージェント ★ 保存済み API
このサイトについて 私たちについて 方法論 データソース 編集方針 お問い合わせ 免責事項

🧭 ガイドビュー
遺伝学が初めてですか? 閲覧しながら、すべての用語をわかりやすく説明します。同じページに、サポートが組み込まれています。

⚡ 専門家の見解
生物学はすでにご存知の方へ。コンテンツだけをすっきりとコンパクトに、余分な説明なしでお届けします。これがデフォルト表示です。

表示言語
ライトモード

Research

Important Discoveries in Gene Editing

The papers that changed what was possible, each summarised and linked to the original.

このリストの作り方

Eleven papers, from the first recognition of what CRISPR was for to the first patients treated with prime editing. Each entry explains what changed and links to the original publication.

#エントリーカテゴリー ステータス
1 A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity The paper that turned CRISPR from a curiosity of bacterial immunity into a programmable… Foundational
2 Multiplex genome engineering using CRISPR/Cas systems One of the two January 2013 papers showing that CRISPR works inside human cells. Foundational
3 RNA-guided human genome engineering via Cas9 The companion January 2013 paper from George Church's laboratory, published the same day. Foundational
4 Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage The paper that introduced base editing — chemistry instead of cutting. Method
5 Search-and-replace genome editing without double-strand breaks or donor DNA The paper introducing prime editing — writing new sequence directly into the genome. Method
6 CRISPR provides acquired resistance against viruses in prokaryotes The experiment, performed at a yogurt company, that proved CRISPR is a bacterial immune… Foundational
7 CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia The first published clinical results showing CRISPR editing produced benefit in patients. Clinical
8 CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis The first report of CRISPR administered into a human bloodstream to edit a gene inside… Clinical
9 Patient-specific in vivo gene editing to treat a rare genetic disease The first gene-editing medicine designed and manufactured for a single patient. Clinical
10 Prime editing for p47phox-deficient chronic granulomatous disease The first published evidence that prime editing works in human patients. Clinical
11 Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements The insight that CRISPR spacers come from viruses — the origin of the whole field. Foundational
このリストでわかること・わからないことA curated selection, not a systematic review. We summarise and link; we do not reproduce copyrighted articles.
Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026